Should FDA, and other authorities, approve the SARS-CoV-2/COVID-19 vaccines? – A scientific perspective

COVID-19 is a recently labeled infectious disease that is presumably caused by a novel coronavirus labeled as SARS-CoV-2.

It is important to note that COVID-19 is not based on any defined and specific symptoms but common and general flu-like potentially treatable with antibiotic regimens [1]. However, medical experts and regulatory authorities, in particular FDA, have adopted an official position that illness is because of a viral infection caused by SARS-CoV-2. Being a viral disease led to a policy decision that a vaccine is needed for its treatment that is to be developed. The pharmaceutical industry has made great efforts in collaboration with the authorities to develop vaccines quickly. There have been media reports that some vaccines are at a late development stage and ready to be submitted to the FDA for marketing approval.

Continue here

Related Posts